829
Views
1
CrossRef citations to date
0
Altmetric
Commentary

Predicting Outcomes in NSCLC: Staging or Biology or Both?

ORCID Icon &

REFERENCES

  • Park S, Park S, Lee SH, et al. Nutritional status in the era of target therapy: poor nutrition is a prognostic factor in non-small cell lung cancer with activating epidermal growth factor receptor mutations. Korean J Intern Med. 2016;31:1140–1149. doi:10.3904/kjim.2015.062.
  • Trestini I, Gkountakos A, Carbognin L, et al. Muscle derangement and alteration of the nutritional machinery in NSCLC. Crit Rev Oncol Hematol. 2019;141:43–53.
  • Kaya SO, Akcam TI, Ceylan KC, et al. Is preoperative protein-rich nutrition effective on postoperative outcome in non-small cell lung cancer surgery? A prospective randomized study. J Cardiothorac Surg. 2016;11:4717613.
  • Li S, Zhang W, Yang Z, et al. Systemic inflammation score as a novel prognostic indicator for patients undergoing video-assisted thoracoscopic surgery lobectomy for non-small-cell lung cancer. J Invest Surg. 2021;34(4):428–440. doi:10.1080/08941939.2019.1641169.
  • Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140:883–899.
  • Liu H, Wu Y, Wang Z, et al. Pretreatment platelet-to-lymphocyte ratio (PLR) as a predictor of response to first-line platinum-based chemotherapy and prognosis for patients with non-small cell lung cancer. J Thorac Dis. 2013;5:783–789.
  • Cehreli R, Yavuzsen T, Ates H, et al. Can inflammatory and nutritional serum markers predict chemotherapy outcomes and survival in advanced stage nonsmall cell lung cancer patients? Biomed Res Int. 2019;2019:1648072.
  • Grose D, Morrison DS, Devereux G, et al. The impact of comorbidity upon determinants of outcome in patients with lung cancer. Lung Cancer. 2015;87:186–192.
  • Zhu L, Li X, Shen Y, et al. A new prognostic score based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Onco Targets Ther. 2016;9:4879–4886.
  • Forrest LM, McMillan DC, McArdle CS, et al. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer. 2003;89:1028–1030.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.